Evoke Wealth’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,300
| Closed | -$225K | – | 161 |
|
|
2024
Q1 | $225K | Buy |
+3,300
| New | +$225K | 0.01% | 364 |
|
|
2023
Q3 | – | Sell |
-3,750
| Closed | -$211K | – | 377 |
|
|
2023
Q2 | $211K | Buy |
+3,750
| New | +$211K | 0.01% | 332 |
|
|
2022
Q4 | – | Sell |
-3,300
| Closed | -$216K | – | 532 |
|
|
2022
Q3 | $216K | Hold |
3,300
| – | – | 0.01% | 307 |
|
|
2022
Q2 | $201K | Hold |
3,300
| – | – | 0.01% | 310 |
|
|
2022
Q1 | $207K | Hold |
3,300
| – | – | 0.01% | 348 |
|
|
2021
Q4 | $250K | Hold |
3,300
| – | – | 0.01% | 337 |
|
|
2021
Q3 | $369K | Hold |
3,300
| – | – | 0.01% | 259 |
|
|
2021
Q2 | $534K | Hold |
3,300
| – | – | 0.02% | 234 |
|
|
2021
Q1 | $402K | Hold |
3,300
| – | – | 0.02% | 237 |
|
|
2020
Q4 | $505K | Hold |
3,300
| – | – | 0.03% | 150 |
|
|
2020
Q3 | $276K | Hold |
3,300
| – | – | 0.02% | 181 |
|
|
2020
Q2 | $243K | Hold |
3,300
| – | – | 0.02% | 176 |
|
|
2020
Q1 | $140K | Hold |
3,300
| – | – | 0.02% | 218 |
|
|
2019
Q4 | $201K | Buy |
+3,300
| New | +$201K | 0.03% | 218 |
|